VERU
Veru Inc
NASDAQ · Pharmaceuticals
$2.34
+0.10 (+4.46%)
Open$2.24
Previous Close$2.24
Day High$2.37
Day Low$2.21
52W High$39.30
52W Low$23.79
Volume—
Avg Volume337.7K
Market Cap37.37M
P/E Ratio21.34
EPS$1.35
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+1,501.7% upside
Current
$2.34
$2.34
Target
$37.48
$37.48
$21.76
$37.48 avg
$51.92
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 7.40M | 6.59M | 7.88M |
| Net Income | 1.82M | 1.64M | 1.71M |
| Profit Margin | 24.6% | 24.9% | 21.7% |
| EBITDA | 3.84M | 3.19M | 3.50M |
| Free Cash Flow | 1.31M | 1.30M | 1.17M |
| Rev Growth | -0.5% | +19.2% | -4.5% |
| Debt/Equity | 0.38 | 0.45 | 0.49 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |